Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia

Chen, C., Raung, S., Liao, S., & Chen, S. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.010 · Cited by 79

Expression of MHC class I heavy chain and β2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons

Lindå, H., Hammarberg, H., Piehl, F., Khademi, M., & Olsson, T. P. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00135-6 · Cited by 79

Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson’s disease

Wang, Q., Wang, M., Choi, I., Sarrafha, L., Liang, M., Ho, L., Farrell, K. W., Beaumont, K. G., Sebra, R., Sanctis, C. D., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi8287 · Cited by 88

Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-κB and JNK activation and suppression of COX-2 activity

Xing, B., Liu, M., & Bing, G. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.029 · Cited by 79

Gene Therapy in Parkinsonʼs Disease

Feng, L., & Maguire‐Zeiss, K. A. (2010) · CNS Drugs · doi:10.2165/11533740-000000000-00000 · Cited by 80

The influence of cannabinoids on generic traits of neurodegeneration

Fagan, S. G., & Campbell, V. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12492 · Cited by 78

Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy

Nagatsu, T. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200061 · Cited by 78

Activated microglia cause superoxide-mediated release of iron from ferritin

Yoshida, T., Tanaka, Μ., Sotomatsu, A., & Hirai, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11490-n · Cited by 79

MHC class II exacerbates demyelination in vivo independently of T cells

Hiremath, M. M., Chen, V. S., Suzuki, K., Ting, J. P.-Y., & Matsushima, G. K. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.034 · Cited by 77

LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s

Wallings, R. L., Herrick, M. K., & Tansey, M. G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00443 · Cited by 80

Resveratrol Protects Cortical Neurons against Microglia‐mediated Neuroinflammation

Zhang, F., Wang, H., Wu, Q., Lu, Y., Nie, J., Xie, X., & Shi, J. (2012) · Phytotherapy Research · doi:10.1002/ptr.4734 · Cited by 77

Dopamine agonists and neuroprotection in Parkinson's disease

Schapira, A. H. V. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.9.s3.9.x · Cited by 77

Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: Evidence for uncoupled regulation of mPGES‐1 and COX‐2

de Oliveira, A. C. P., Candelario‐Jalil, E., Bhatia, H. S., Lieb, K., Hüll, M., & Fiebich, B. L. (2008) · Glia · doi:10.1002/glia.20658 · Cited by 79

Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases

Santiago, A. R., Baptista, F. I., Santos, P. F., Cristóvão, G., Ambrósio, A. F., Cunha, R. A., & Gomes, C. A. (2014) · Mediators of Inflammation · doi:10.1155/2014/465694 · Cited by 81

Microglial cells in neurodegenerative disorders.

Wojtera, M., Sikorska, B., Sobów, T., & Liberski, P. P. (2005) · PubMed · Cited by 78

Inflammation and depression: Is there a causal connection with dementia?

E.Leonard, B., & Myint, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033243 · Cited by 76

Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis

Guo, J., Yue, F., Song, D., Bousset, L., Liang, X., Tang, J., Yuan, L., Li, W., Melki, R., Tang, Y. C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03369-x · Cited by 74

Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson’s disease

Chi, Y., Fan, Y., He, L., Liu, W. Y., Wen, X., Zhou, S., Wang, X., Zhang, C., Kong, H., Sonoda, L., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00677.x · Cited by 76

Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

Mounsey, R. B., Mustafa, S., Robinson, L., Ross, R. A., Riedel, G., Pertwee, R. G., & Teismann, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.024 · Cited by 75

Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats

Lima, M. D. M. S., Reksidler, A. B., Zanata, S. M., Machado, H. B., Tufik, S., & Vital, M. A. B. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.016 · Cited by 76

Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism

Annese, V., Herrero, M. T., Pentima, M. D., Gómez, A., Lombardi, L., Ros, C. M. B., de Pablos, V., Fernández‐Villalba, E., & Stefano, M. E. D. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0718-8 · Cited by 78

Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.

Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J. J., & Ogawa, N. (2004) · PubMed · doi:10.18926/amo/32105 · Cited by 76

l ‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?

Carta, A. R., Mulas, G., Bortolanza, M., Duarte, T. T., Pillai, E., Fisone, G., Raisman‐Vozari, R., & Bel, E. A. D. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13482 · Cited by 80

Hyperoside inhibits lipopolysaccharide-induced inflammatory responses in microglial cells via p38 and NFκB pathways

Fan, H.-H., Zhu, L.-B., Li, T., Zhu, H. F., Wang, Y., Ren, X., Hu, B., Huang, C.-P., Zhu, J., & Zhang, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.004 · Cited by 76

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases

Batista, A. F., Bodart‐Santos, V., Felice, F. G. D., & Ferreira, S. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0593-6 · Cited by 78

An animal model of prophylactic cranial irradiation: Histologic effects at acute, early and delayed stages

Mildenberger, M., Beach, T. G., McGeer, E. G., & Ludgate, C. M. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90440-u · Cited by 76

Parkinson's disease and inflammatory changes

Barcia, C., Barreiro, A. F., Poza, M., & Herrero, M. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033170 · Cited by 76

German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia — Longitudinal observations

Wszołek, Z. K., Vieregge, P., Uitti, R. J., Gasser, T., Yasuhara, O., McGeer, P. L., Berry, K., Calne, D. B., Vingerhoets, F. J. G., Klein, C., et al. (1997) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(97)00013-8 · Cited by 76

Mechanisms of alpha-synuclein toxicity: An update and outlook

Brás, I. C., Xylaki, M., & Outeiro, T. F. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.005 · Cited by 78

The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease

Yin, R. L., Xue, J., Tan, Y., Fang, C., Hu, C., Yang, Q., Mei, X., & Qi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9923331 · Cited by 82

Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice

Hou, Y., Xie, G., Liu, X., Li, G., Jia, C., Xu, J., & Wang, B. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4169-6 · Cited by 76

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease

Siani, F., Greco, R., Levandis, G., Ghezzi, C., Daviddi, F., Demartini, C., Vegeto, E., Armentero, M., & Blandini, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00306 · Cited by 77

Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease

Kuštrimović, N. Z., Marino, F., & Cosentino, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181009161048 · Cited by 74

Potential Treatment of Parkinson’s Disease with Omega-3 Polyunsaturated Fatty Acids

Li, P., & Song, C. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1735143 · Cited by 74

The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson’s disease and targeted therapies

Amin, R., Quispe, C., Docea, A. O., Ydyrys, A., Kulbayeva, M., Durna Daştan, S., Calina, D., & Sharifi-Rad, J. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105376 · Cited by 74

PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target

Mogensen, F. L., Scafidi, A., Poli, A., & Michelucci, A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02776-z · Cited by 80

Exposure of foetal neural progenitor cells to IL‐1β impairs their proliferation and alters their differentiation – a role for maternal inflammation?

Crampton, S. J., Collins, L., Toulouse, A., Nolan, Y. M., & O’Keeffe, G. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07634.x · Cited by 75

Artemisinin Attenuates Lipopolysaccharide-Stimulated Proinflammatory Responses by Inhibiting NF-κB Pathway in Microglia Cells

Zhu, C., Xiong, Z., Chen, X., Peng, F., Hu, X., Chen, Y., & Wang, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035125 · Cited by 74

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease

Koppula, S., Kumar, H., More, S. V., Kim, B., Kim, I. S., & Choi, D. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810608 · Cited by 76

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) 38 and PACAP4–6 Are Neuroprotective through Inhibition of NADPH Oxidase: Potent Regulators of Microglia-Mediated Oxidative Stress

Yang, S., Yang, J. H., Yang, Z., Chen, P., Fraser, A., Zhang, W., Pang, H., Gao, X., Wilson, B. C., Hong, J., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102236 · Cited by 75

Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system)

Ishizawa, K., Komori, T., Arai, N., Mizutani, T., & Hirose, T. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2007.00855.x · Cited by 74

Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation

Peng, J., Stevenson, F. F., Oo, M. L., & Andersen, J. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.045 · Cited by 76

GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury

Huang, X., Kim, J.-M., Kong, T. H., Park, S. R., Ha, Y. S., Kim, M. H., Park, H., Yoon, S. H., Park, H. C., Park, J. O., et al. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.10.022 · Cited by 74

Neurotransmission systems in Parkinson’s disease

Moghaddam, H. S., Zare-Shahabadi, A., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0068 · Cited by 78

Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System

Lawana, V., Singh, N., Sarkar, S., Charli, A., Jin, H., Anantharam, V., Kanthasamy, A. G., & Kanthasamy, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9746-5 · Cited by 73

Respiratory burst activity in brain macrophages: a flow cytometric study on cultured rat microglia

Banati, R. B., Rothe, G., Valet, G., & Kreutzberg, G. W. (1991) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1991.tb00718.x · Cited by 74

Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease

Yin, P., Wang, X., Wang, S., Wei, Y., Feng, J., & Zhu, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00466 · Cited by 73

TSPO imaging in animal models of brain diseases

Camp, N. V., Lavisse, S., Roost, P., Gubinelli, F., Hillmer, A. T., & Boutin, H. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05379-z · Cited by 71

Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells

Lee, K., Jung, S. Y., Choi, S., & Yang, E. J. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-196 · Cited by 73

Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease

Hirrlinger, J., Schulz, J. B., & Dringen, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01013.x · Cited by 73

Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's desease

Youdim, M. B. H., & Lavie, L. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00388-2 · Cited by 73

NF‐κB/p53‐activated inflammatory response involves in diquat‐induced mitochondrial dysfunction and apoptosis

Choi, S. E., Park, Y. S., & Koh, H. C. (2018) · Environmental Toxicology · doi:10.1002/tox.22552 · Cited by 71

Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging

Ryu, Y., Go, J., Park, H., Choi, Y., Seo, Y. J., Choi, J. H., Rhee, M., Lee, T. G., Lee, C., & Kim, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108173 · Cited by 74

Inhibition of microglial inflammation by the MLK inhibitor CEP‐1347

Lund, S., Pörzgen, P., Mortensen, A. L., Hasseldam, H., Bozyczko‐Coyne, D., Morath, S., Härtung, T., Bianchi, M., Ghezzi, P., Bsibsi, M., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03014.x · Cited by 72

Characterisation of two new monoclonal antibodies directed against rat microglia

Gehrmann, J., & Kreutzberg, G. W. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903130302 · Cited by 72

Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death

Kumar, H., Koppula, S., Kim, I., More, S. V., Kim, B.-W., & Choi, D. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311211080012 · Cited by 70

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies

Refolo, V., & Stefanova, N. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00263 · Cited by 72

Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway

Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Cells · doi:10.3390/cells10020230 · Cited by 71

In vivo evidence for microglial activation in neurodegenerative dementia

Cagnin, A., Kassiou, M., Meikle, S. R., & Banati, R. B. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00694.x · Cited by 71

Quantitative1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease

Boska, M. D., Lewis, T. B., Destache, C. J., Benner, E. J., Nelson, J. A., Uberti, M., Mosley, R. L., & Gendelman, H. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4364-04.2005 · Cited by 72

Downregulation of miR‐7116‐5p in microglia by MPP + sensitizes TNF‐α production to induce dopaminergic neuron damage

He, Q., Wang, Q., Yuan, C., & Wang, Y. (2017) · Glia · doi:10.1002/glia.23153 · Cited by 71

Targeting the Dopaminergic System in Autoimmunity

Vidal, P. M., & Pacheco, R. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09834-5 · Cited by 71

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils

Russo, I., Kaganovich, A., Ding, J., Landeck, N., Mamais, A., Varanita, T., Biosa, A., Tessari, I., Bubacco, L., Greggio, E., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.012 · Cited by 68

Imaging neuroinflammation in multiple sclerosis using TSPO-PET

Airas, L. M., Rissanen, E., & Rinne, J. O. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0147-6 · Cited by 78

Neuroinflammation in Synucleinopathies

Lim, S., Chun, Y., Lee, J. S., & Lee, S. (2016) · Brain Pathology · doi:10.1111/bpa.12371 · Cited by 70

Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease

Chen, K., Wang, H., Ilyas, I., Mahmood, A., & Hou, L. (2023) · Brain Sciences · doi:10.3390/brainsci13040634 · Cited by 82

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease

Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 79

The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson’s Disease

Mackie, P. M., Lebowitz, J., Saadatpour, L., Nickoloff, E., Gaskill, P. J., & Khoshbouei, H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.020 · Cited by 75

Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease

Mishra, A., & Brinton, R. D. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00312 · Cited by 71

Innate immune responses to paraquat exposure in a Drosophila model of Parkinson’s disease

Maitra, U., Scaglione, M., Chtarbanova, S., & O’Donnell, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-48977-6 · Cited by 79

Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation

Cabezudo, D., Baekelandt, V., & Lobbestael, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00376 · Cited by 77

Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia

Carreño‐Müller, E., Herrera, A. J., de Pablos, R. M., Tomás‐Camardiel, M., Venero, J. L., Cano, J., & Machado, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01634.x · Cited by 70

Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter

Hartmann, A., Hunot, S., & Hirsch, É. C. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.004 · Cited by 70

Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease

Walker, D. G., Beach, T. G., Xu, R., Lile, J. D., Beck, K. D., McGeer, E. G., & McGeer, P. L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00131-0 · Cited by 70

Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role

Zucca, F. A., Capucciati, A., Bellei, C., Sarna, M., Sarna, T., Monzani, E., Casella, L., & Zecca, L. (2023) · IUBMB Life · doi:10.1002/iub.2654 · Cited by 69

Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood

Desplats, P., Gutierrez, A. M., Antonelli, M. C., & Frasch, M. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.013 · Cited by 74

Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease

Riederer, P. F., Monoranu, C., Strobel, S., Iordache, T., & Sian‐Hülsmann, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02414-z · Cited by 69

A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation.

Miyazono, M., Iwaki, T., Kitamoto, T., Kaneko, Y., Doh‐ura, K., & Tateishi, J. (1991) · PubMed Central · Cited by 69

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

Kadiu, I., Glanzer, J. G., Kipnis, J., Gendelman, H. E., & THOMAS, M. P. (2005) · Neurotoxicity Research · doi:10.1007/bf03033818 · Cited by 69

Neuroinflammation: Microglial Activation During Sepsis

Michels, M., Danielski, L. G., Dal‐Pizzol, F., & Petronilho, F. C. (2014) · Current Neurovascular Research · doi:10.2174/1567202611666140520122744 · Cited by 70

Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats

Lee, E. Y., Lee, J. E., Park, J. H., Shin, I. C., & Koh, H. C. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.016 · Cited by 71

Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex

Ji, K., Eu, M. Y., Kang, S., Gwag, B. J., Jou, I., & Joe, E.-H. (2008) · Glia · doi:10.1002/glia.20677 · Cited by 69

Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats

Liu, X., Zhou, H., Pan, Y., Liang, X., Niu, D.-B., Xue, B., Li, F., He, Q., Wang, X., & Wang, X.-M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.028 · Cited by 69

Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?

Caggiu, E., Paulus, K. S., Arru, G., Piredda, R., Sechi, G., & Sechi, L. A. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.007 · Cited by 69

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 75

Role of MCP-1 and CCR2 in alcohol neurotoxicity

Zhang, K., & Luo, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.030 · Cited by 70

Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues

Ferrari, R., Manzoni, C., & Hardy, J. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.006 · Cited by 74

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease

Riederer, P. F., Nagatsu, T., Youdim, M. B. H., Wulf, M., Dijkstra, J. M., & Sian‐Hülsmann, J. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02630-9 · Cited by 71

Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease

Thome, A. D., Standaert, D. G., & Harms, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140566 · Cited by 68

Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants

Klegeris, A., & McGeer, P. L. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90067-1 · Cited by 68

Lesions outside the CNS in Parkinson's disease

Djaldetti, R., Lev, N., & Melamed, E. (2009) · Movement Disorders · doi:10.1002/mds.22172 · Cited by 68

Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: Similarity with paraquat neurotoxicity

Kumar, A., Singh, B. K., Ahmad, I., Shukla, S., Patel, D. K., Srivastava, G., Kumar, V., Pandey, H. P., & Singh, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.12.028 · Cited by 70

Inflammatory Regulation of ATP Binding Cassette Efflux Transporter Expression and Function in Microglia

Gibson, C. J., Hossain, M. M., Richardson, J. R., & Aleksunes, L. M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196543 · Cited by 68

The Role of Glia in Alpha-Synucleinopathies

Fellner, L., & Stefanova, N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8340-3 · Cited by 69

Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation

Li, F., Lu, X.-Z., Liang, X., Zhou, H.-F., Xue, B., Liu, X., Niu, D.-B., Han, J., & Wang, X. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.054 · Cited by 68

The Isothiocyanate Isolated from Moringa oleifera Shows Potent Anti-Inflammatory Activity in the Treatment of Murine Subacute Parkinson's Disease

Giacoppo, S., Rajan, T. S., Nicola, G. R. D., Iori, R., Rollin, P., Bramanti, P., & Mazzon, E. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1828 · Cited by 71

Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra

Knott, C., Stern, G. M., Kingsbury, A. E., Welcher, A. A., & Wilkin, G. P. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00008-1 · Cited by 68

Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections)

Ringheim, G. E., & Conant, K. E. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.013 · Cited by 67

Effects of Ceftriaxone on the Behavioral and Neuronal Changes in an MPTP-Induced Parkinson’s Disease Rat Model

Ho, S.-C., Hsu, C.-C., Pawlak, C. R., Tikhonova, M. A., Lai, T.-J., Amstislavskaya, T. G., & Ho, Y.-J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.022 · Cited by 65

Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?

Cebrián, C., Loike, J. D., & Sulzer, D. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_356 · Cited by 65

Expression of the histocompatibility glycoprotein HLA-DR in neurological disease

McGeer, P. L., Itagaki, S., & McGeer, E. G. (1988) · Acta Neuropathologica · doi:10.1007/bf00689592 · Cited by 420

HLA-DR reactive microglia in Parkinson's disease

Itagaki, S., McGeer, P. L., & McGeer, E. G. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90252-9 · Cited by 5

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR

McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791

Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain

Styren, S. D., Civin, W. H., & Rogers, J. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90054-v · Cited by 191